Teriflunomide Tablet, Film Coated
Product Images NDC 70771-1010

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 70771-1010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7 mg (9d8b9750 Bbe3 472b Bc34 74d07baea548 01)

Teriflunomide is a medication that comes in tablet form with a strength of 7mg per tablet. The medication guide should be dispensed separately to each patient. Each tablet contains Terfunomide 7mg, and the usual dosage is one tablet orally once daily. The tablet can be taken with or without food. It is recommended to store the medicine between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Cadia Healthcare Ltd., located in Vadodara, Ahmedabad, India, is the manufacturer of Terfunomide. The medicine should be kept out of reach of children.*

FDA Label Image

14 mg (9d8b9750 Bbe3 472b Bc34 74d07baea548 02)

This is a description of Teriflunomide tablets with information on dosage, how to take the medication, storage, and the manufacturer. Each tablet contains 14mg of Teriflunomide and the usual dosage is a single tablet orally once daily. The tablets can be taken with or without food and should be stored between 20°C and 25°C. The medication guide, provided separately to each patient, should be consulted before use. The manufacturer of the tablets is Cadila Healthcare Ltd., with a location in Metoda, Abmedabad, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.